The Temple Health CME Program

The Temple Health CME Program embraces evidence-based programs which promote new concepts in patient safety and enhance excellence in care.


Upcoming Programs in the 2019 CME Program Series

 

Atlantic Regional Hematopathology Meeting

Saturday, May 18, 2019
8:30am – 3pm
Fox Chase Cancer Center Auditorium
333 Cottman Ave., Philadelphia, PA

Hematopathology is a dynamic field that has always been at the forefront of clinical research within the scope of pathology. However, pathologists are often limited in the cases they are exposed to throughout their daily practice, making it challenging to stay up-to-date on the latest advances in the field.

Fox Chase Cancer Center and The Temple Health Office for Continuing Medical Education invite you to join Fox Chase physicians, keynote speakers from Duke Center for Genomic and Computational Biology and Alberta University, and other colleagues from the region as they review complex cases and discuss approaches to diagnosing these cases.

Participants will review indicators/markers and test results to understand the reasons specific diagnoses were reached. Two seminars on the diverse aspects of T-cell lymphoma pathogenesis and molecular makeup will also be offered. Through an interactive format, attendees will enhance their ability to incorporate recent molecular immunophenotypic and genetic information in their interpretations.

LEARNING OBJECTIVES

At the end of this activity, participants should be able to:
  • Recognize the indicators/markers and test results to look for in complex cases to aid in diagnosis
  • When appropriate, incorporate recent molecular immunophenotypic and genetic information when interpreting results, determining diagnoses and selecting therapies 
  • Discuss the latest advances related to molecular analysis of T-cell lymphomas

 

REGISTRATION

Register for Event

Complimentary registration for all participants
Includes breakfast, lunch, coffee breaks & program materials

Registration Deadline is Tuesday, May 15, 2019 

INTENDED AUDIENCE

The program is designed for hematopathologists, pathologists of other subspecialties, hematologists/oncologists, radiation oncologists, internists, primary care providers, fellows and residents of pathology, oncology and other specialties.

PROGRAM DIRECTORS

Mariusz A. Wasik, MD
Professor and Chair of Pathology, Department of Pathology
Associate Director of Cancer Center
Fox Chase Cancer Center

Tahseen I. Al-Saleem, MD
Professor, Department of Pathology
Fox Chase Cancer Center

PLANNING COMMITTEE MEMBERS

Essel Dulaimi Al-Saleem, MD
Associate Professor, Department of Pathology
Director, Outpatient Laboratory
Fox Chase Cancer Center

Henry C. Fung, MD, FACP, FRCPE
Vice-Chair, Hematology Program, Department of Hematology/Oncology
Fox Chase Cancer Center
Director, Fox Chase-Temple BMT Program

Reza Nejati, MD
Assistant Professor, Department of Pathology
Fox Chase Cancer Center

KEYNOTE SPEAKERS

Sandeep Dave, MD, MS
Professor, Division of Hematologic Malignancies and Cellular Therapy,
Department of Medicine, Duke Center for Genomic and Computational Biology

 Genomics of Selected T-cell Lymphoma Subtypes

 Raymond Lai, MD, PhD
Professor, Department of Laboratory Medicine and Pathology,
Faculty of Medicine and Dentistry, University of Alberta

Expression of Stem Cell Genes in ALK+ T-cell Lymphoma: Mechanisms and Pathogenic Consequences

 

SUBMISSION OF ABSTRACTS

To submit an abstract for consideration, please send the following by
Monday, April 15, 2019 to TempleHealthCME@tuhs.temple.edu:

  1. One-page abstract, case description and diagnosis in Microsoft Word (no slides)
  2. In the abstract, specify the name, credential, affiliation and e-mail of the person who will presenting the case if selected for oral presentation

Notification of cases selected: Monday, April 22, 2019

If you are selected for an ORAL PRESENTATION, see below:

  • Oral presentations consist of a 15-minute lecture
  • Please provide the CME Office (TempleHealthCME@tuhs.temple.edu) with the following by Monday, May 13, 2019:
  • Set of PowerPoint slides with a brief patient history and a couple of images to post in a collaboration site prior to the event for reference (please abstain from providing a diagnosis or any discussion)
  • Electronic copy of your PowerPoint slides as you will present them
  • Declaration of commercial relationships of the person presenting the case

If you are selected for a POSTER EXHIBIT, see below:

  • Poster exhibits will be displayed all day and can be presented during breaks
  • Please bring a hard copy of your poster on the day of the event; we will have 4'x 6' poster boards with stands available  

 

Inquiries: Lucía Tono, PhD, JD, MEd |  215-728-3797 | Lucia.Tono-Ramirez@tuhs.temple.edu

ACCREDITATION STATEMENT

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.   

DESIGNATION STATEMENT

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. 

DISCLOSURE POLICY

It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest pertaining to the content of the activity and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.

 

Register for Event